BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17080264)

  • 1. Neurogenic diabetes insipidus.
    Jane JA; Vance ML; Laws ER
    Pituitary; 2006; 9(4):327-9. PubMed ID: 17080264
    [No Abstract]   [Full Text] [Related]  

  • 2. Desmopressin as a Novel Long-Term Treatment in Postural Tachycardia Syndrome Patients with Polyuria.
    Seeley MC; Thynne TR; Braund WJ; Worthley DL; Gallagher C; Sanders P; Lau DH
    Am J Med; 2021 Sep; 134(9):e486-e487. PubMed ID: 33865825
    [No Abstract]   [Full Text] [Related]  

  • 3. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
    Almutlaq N; Eugster EA
    J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on "Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study"--efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus.
    Kamoi K
    Endocr J; 2013; 60(9):1115. PubMed ID: 23863202
    [No Abstract]   [Full Text] [Related]  

  • 5. Langerhans cell histiocytosis.
    Kumar M; Menon AS
    Indian J Med Res; 2018 Sep; 148(3):351-352. PubMed ID: 30425231
    [No Abstract]   [Full Text] [Related]  

  • 6. Polyuria due to central diabetes insipidus presenting as an early manifestation of acute myeloid leukemia.
    Loukidis K; Papadakis E; Anagnostou N; Kiriklidou P; Gatsa E; Karagianni A; Patinakis P; Tsakiris D; Kioumi A; Korantzis I
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):399-400. PubMed ID: 22895244
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
    Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
    Marín GR; Baspineiro B; Vilca I
    Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profound hypernatremia due to central diabetes insipidus.
    Vaqar A; Rafiq A; Javaid KH; Parveen R; Sadaf R
    J Coll Physicians Surg Pak; 2012 Jun; 22(6):409-11. PubMed ID: 22630107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of neurogenic diabetes insipidus.
    Chanson P; Salenave S
    Ann Endocrinol (Paris); 2011 Dec; 72(6):496-9. PubMed ID: 22071315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of subcutaneous DDAVP in infants with central diabetes insipidus.
    Blanco EJ; Lane AH; Aijaz N; Blumberg D; Wilson TA
    J Pediatr Endocrinol Metab; 2006 Jul; 19(7):919-25. PubMed ID: 16995572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin regulates the renal Na+-Cl- cotransporter.
    Gamba G
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F500-1. PubMed ID: 20042457
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term hormone replacement treatment in a horse with central diabetes insipidus.
    Durie I; van Galen G
    J Vet Intern Med; 2020 Mar; 34(2):1013-1017. PubMed ID: 31960998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patient with essential hypernatremia had good response to desmopressin acetate therapy.
    Guo Q; Lu J; Mu Y; Dou J; Pan C
    Neuro Endocrinol Lett; 2010; 31(5):588-93. PubMed ID: 21173753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incomplete central diabetes insipidus in living kidney transplant patient].
    Yamaguchi K; Oka N; Izakii H; Masayuki T; Tomoharu F; Kanayama HO; Kan M
    Hinyokika Kiyo; 2008 Jul; 54(7):493-6. PubMed ID: 18697495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central diabetes insipidus].
    Oiso Y
    Nihon Rinsho; 2006 May; Suppl 1():187-9. PubMed ID: 16776123
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of central diabetes insipidus with oral desmopressin in a patient with ectrodactyly and cleft lip/palate (ECP) syndrome.
    Ozaydin E; Aycan Z; Yusufoğlu AM; Cetinkaya E; Ergen S; Unal S; Köse G
    Turk J Pediatr; 2009; 51(1):89-93. PubMed ID: 19378901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of sarcoidosis with diabetes insipidus].
    Sugiyama K; Mukae H; Sakamoto N; Iwata A; Amenomori M; Ishimoto H; Miyazaki H; Hisatomi K; Ishii H; Nakayama S; Ishimatsu Y; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):105-9. PubMed ID: 17313038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.
    Misgar RA; Rasool A; Wani AI; Bashir MI
    J Endocrinol Invest; 2021 Dec; 44(12):2855-2856. PubMed ID: 34215999
    [No Abstract]   [Full Text] [Related]  

  • 20. 'If there were water we should stop and drink': neurofibromatosis presenting with diabetes insipidus.
    Barry R; O' Connor A; Awang MH; O' Toole O
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29440241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.